Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Therapeutic Advances in Vaccines
|
November 4, 2014
Liposomes as vaccine delivery systems: a review of the recent advances
Reto A Schwendener
Advances in Experimental Medicine and Biology
|
January 26, 2008
Liposomes in biology and medicine
Reto A Schwendener
Methods in Molecular Medicine
|
December 9, 2004
Cytotoxic tumor targeting with scFv antibody-modified liposomes
Cornelia Marty, Reto A Schwendener
Methods in Molecular Biology (Clifton, N.J.)
|
January 15, 2010
Liposome formulations of hydrophobic drugs
Reto A Schwendener, Herbert Schott
Methods in Molecular Biology (Clifton, N.J.)
|
November 13, 2016
Liposome Formulations of Hydrophobic Drugs
Reto A Schwendener, Herbert Schott
Bioorganic & Medicinal Chemistry
|
September 12, 2009
Synthesis and in vitro activities of new anticancer duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) via a phosphodiester bonding
Herbert Schott, Sarah Schott, Reto A Schwendener
European Journal of Medicinal Chemistry
|
May 17, 2005
Synthesis and anticancer activities of amphiphilic 5-fluoro-2'-deoxyuridylic acid prodrugs
Peter S Ludwig, Reto A Schwendener, Herbert Schott
Plos One
|
December 15, 2012
Depletion of resident macrophages does not alter sensory regeneration in the avian cochlea
Mark E Warchol, Reto A Schwendener, Keiko Hirose
Methods in Molecular Biology (Clifton, N.J.)
|
January 15, 2010
Liposome-based vaccines
Reto A Schwendener, Burkhard Ludewig, Andreas Cerny, et al.
Plos One
|
June 19, 2014
DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization
Charlene M Downey, Mehrnoosh Aghaei, Reto A Schwendener, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Therapeutic Advances in Vaccines
|
November 4, 2014
Liposomes as vaccine delivery systems: a review of the recent advances
Reto A Schwendener
Advances in Experimental Medicine and Biology
|
January 26, 2008
Liposomes in biology and medicine
Reto A Schwendener
Methods in Molecular Medicine
|
December 9, 2004
Cytotoxic tumor targeting with scFv antibody-modified liposomes
Cornelia Marty, Reto A Schwendener
Methods in Molecular Biology (Clifton, N.J.)
|
January 15, 2010
Liposome formulations of hydrophobic drugs
Reto A Schwendener, Herbert Schott
Methods in Molecular Biology (Clifton, N.J.)
|
November 13, 2016
Liposome Formulations of Hydrophobic Drugs
Reto A Schwendener, Herbert Schott
Bioorganic & Medicinal Chemistry
|
September 12, 2009
Synthesis and in vitro activities of new anticancer duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) via a phosphodiester bonding
Herbert Schott, Sarah Schott, Reto A Schwendener
European Journal of Medicinal Chemistry
|
May 17, 2005
Synthesis and anticancer activities of amphiphilic 5-fluoro-2'-deoxyuridylic acid prodrugs
Peter S Ludwig, Reto A Schwendener, Herbert Schott
Plos One
|
December 15, 2012
Depletion of resident macrophages does not alter sensory regeneration in the avian cochlea
Mark E Warchol, Reto A Schwendener, Keiko Hirose
Methods in Molecular Biology (Clifton, N.J.)
|
January 15, 2010
Liposome-based vaccines
Reto A Schwendener, Burkhard Ludewig, Andreas Cerny, et al.
Plos One
|
June 19, 2014
DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization
Charlene M Downey, Mehrnoosh Aghaei, Reto A Schwendener, et al.
Page
of 5